Evidence map›Paper›PMID 42588673›Full record

ArticleCancers2026

Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification.

Federico Venturi, Maria Luisa Orlando, Barbara Corti, Paola Valeria Marchese, Francesca Comito, Barbara Melotti, Elisabetta Magnaterra, Biagio Scotti, Aurora Maria Alessandrini, Leonardo Veneziano and 2 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Federico VenturiDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.ORCID 0000-0001-5053-4172
Maria Luisa OrlandoDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.
Barbara CortiPathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-6555-6227
Paola Valeria MarcheseDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.ORCID 0000-0002-1309-2819
Francesca ComitoDivision of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Barbara MelottiDivision of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Elisabetta MagnaterraDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.ORCID 0000-0002-3263-4353
Biagio ScottiDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.
Aurora Maria AlessandriniOncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Leonardo VenezianoOncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Elena Maria CamaOncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Emi DikaDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-3186-2861

Funding

European Union PRIN 2022-D.D. 104/2022-DIKA EMI-Fin. NextGenerationEU-PNRR-M4C2-Inv. 1.1-Cod. prog. 2022RY8549_002-CUP J53D23003260006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

early-stage melanomamitotic ratenevus-associated melanomarisk stratificationthin melanomatumor-infiltrating lymphocytes

Identifiers

PMID42588673
PMCPMC13465612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.